A detailed history of Envestnet Asset Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 4,978,630 shares of ABBV stock, worth $896 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
4,978,630
Previous 5,051,598 1.44%
Holding current value
$896 Million
Previous $866 Million 13.47%
% of portfolio
0.33%
Previous 0.31%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$163.84 - $199.33 $12 Million - $14.5 Million
-72,968 Reduced 1.44%
4,978,630 $983 Million
Q2 2024

Aug 08, 2024

BUY
$154.79 - $180.76 $59.1 Million - $69 Million
381,871 Added 8.18%
5,051,598 $866 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $15.9 Million - $18.2 Million
99,746 Added 2.18%
4,669,727 $850 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $23.8 Million - $26.8 Million
172,672 Added 3.93%
4,569,981 $708 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $151 Million - $175 Million
1,130,638 Added 34.61%
4,397,309 $655 Million
Q2 2023

Aug 04, 2023

SELL
$132.51 - $164.9 $15.3 Million - $19 Million
-115,099 Reduced 3.4%
3,266,671 $440 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $5.44 Million - $6.27 Million
-37,630 Reduced 1.1%
3,381,770 $539 Million
Q4 2022

Feb 07, 2023

BUY
$138.31 - $165.87 $1.1 Million - $1.32 Million
7,958 Added 0.23%
3,419,400 $553 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $13.4 Million - $15.4 Million
99,724 Added 3.01%
3,411,442 $458 Million
Q2 2022

Aug 03, 2022

SELL
$137.62 - $174.96 $2.02 Million - $2.56 Million
-14,645 Reduced 0.44%
3,311,718 $507 Million
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $18.5 Million - $23 Million
140,424 Added 4.41%
3,326,363 $539 Million
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $5.93 Million - $7.5 Million
55,168 Added 1.76%
3,185,939 $431 Million
Q3 2021

Oct 07, 2021

BUY
$106.4 - $120.78 $18.4 Million - $20.9 Million
172,841 Added 5.84%
3,130,771 $338 Million
Q2 2021

Aug 04, 2021

BUY
$105.21 - $117.21 $8.29 Million - $9.23 Million
78,780 Added 2.74%
2,957,930 $333 Million
Q1 2021

May 04, 2021

BUY
$102.3 - $112.62 $59.2 Million - $65.2 Million
579,176 Added 25.18%
2,879,150 $312 Million
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $2.65 Million - $3.58 Million
32,956 Added 1.45%
2,299,974 $246 Million
Q3 2020

Oct 09, 2020

SELL
$85.91 - $100.83 $265,204 - $311,262
-3,087 Reduced 0.14%
2,267,018 $199 Million
Q2 2020

Jul 08, 2020

BUY
$73.37 - $98.18 $10.9 Million - $14.6 Million
148,701 Added 7.01%
2,270,105 $223 Million
Q1 2020

Apr 23, 2020

BUY
$64.5 - $97.79 $22.5 Million - $34 Million
348,115 Added 19.63%
2,121,404 $162 Million
Q4 2019

Feb 11, 2020

BUY
$72.13 - $90.25 $35 Million - $43.8 Million
485,004 Added 37.65%
1,773,289 $157 Million
Q3 2019

Oct 17, 2019

BUY
$62.98 - $75.72 $7.99 Million - $9.6 Million
126,826 Added 10.92%
1,288,285 $97.5 Million
Q2 2019

Aug 02, 2019

BUY
$65.7 - $83.98 $468,243 - $598,525
7,127 Added 0.62%
1,161,459 $84.5 Million
Q1 2019

May 10, 2019

BUY
$77.14 - $90.79 $4.39 Million - $5.17 Million
56,969 Added 5.19%
1,154,332 $93 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $83.3 Million - $103 Million
1,069,620 Added 3855.46%
1,097,363 $101 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $14.4 Million - $16 Million
-161,891 Reduced 85.37%
27,743 $2.62 Million
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $61,589 - $72,873
-686 Reduced 0.36%
189,634 $17.6 Million
Q1 2018

May 09, 2018

SELL
$92.01 - $123.21 $9.25 Million - $12.4 Million
-100,583 Reduced 34.58%
190,320 $18.2 Million
Q4 2017

Feb 20, 2018

SELL
$89.56 - $98.21 $1.27 Million - $1.39 Million
-14,186 Reduced 4.65%
290,903 $28.1 Million
Q3 2017

Nov 13, 2017

SELL
$69.85 - $89.22 $7.2 Million - $9.2 Million
-103,064 Reduced 25.25%
305,089 $27.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
408,153
408,153 $29.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.